AlzChem Group AG (ALZCF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    AlzChem Group AG

    PNK: ALZCF · Real-Time Price · USD
    101.30
    0.00 (0.00%)
    At close: Apr 30, 2025, 1:48 PM

    AlzChem Income Statement

    Financials in EUR. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 554.23M 678.81M 670.7M 661.11M 661.47M 531.05M 549.42M 563.26M 542.22M 520.07M 476.8M 447.37M 422.29M 411.87M 397.33M 388.84M
    Cost of Revenue
    		 350.52M 497.06M 500.6M 350.59M 366.08M 239.25M 268.12M 273.39M 257.54M 234.88M 193.42M 173.2M 152.17M 141.87M 132.67M 132.39M
    Gross Profit
    		 203.71M 181.75M 170.1M 310.51M 295.4M 291.81M 281.31M 289.87M 284.68M 285.19M 283.38M 274.17M 270.12M 270.01M 264.66M 256.44M
    Operating Income
    		 104.65M 112.88M 108.02M 72.57M 66.84M 71.25M 63.46M 65.71M 65.01M 37.31M 39.26M 38.7M 38.22M 39.14M 37.8M 35.54M
    Interest Income
    		 2.17M 1.66M 1.87M 1.29M 1.04M 2.47M 4.28M 6.56M 7.69M 6.04M 3.72M 1.57M 899K 1.03M 1.01M 769K
    Pretax Income
    		 75.34M 81.94M 76.58M 66.67M 60.22M 41.92M 37.42M 40.7M 41.28M 37.35M 37.15M 36.82M 36.51M 36.95M 34.95M 31.75M
    Net Income
    		 54.08M 58.71M 54.95M 47.76M 43.23M 30.31M 27.63M 30.02M 30.05M 29.06M 27.82M 27.4M 27.59M 26.59M 25.66M 23.2M
    Selling & General & Admin
    		 49.37M 81.58M 116.26M 115.19M 110.69M 108.64M 105.28M 110.39M 108.65M 106.26M 105.82M 100.11M 98.98M 89.77M 87.93M 86.96M
    Research & Development
    		 n/a 4.54M 4.54M 7.85M 7.85M 14.11M 14.11M 10.79M 10.79M 9.69M 9.69M 9.69M 9.69M 6.68M 6.68M 9.36M
    Other Expenses
    		 222.11M 139.52M 55.44M -13.9M -13.9M -11.35M -11.35M -9.54M -9.54M -8.51M -8.51M -8.43M -8.43M -8.79M -8.79M -9.29M
    Operating Expenses
    		 278.6M 248.42M 223.81M 238.06M 228.72M 251.6M 248.24M 259.05M 255.7M 252.81M 249.19M 236.24M 232M 229.38M 225.34M 219.55M
    Interest Expense
    		 5.83M 6.83M 6.88M 7.17M 7.6M 6.16M 5.33M 4.31M 3.03M 2M 1.68M 1.45M 1.27M 1.27M 1.93M 2.87M
    Selling & Marketing Expenses
    		 4.8M 4.8M 4.8M 4.89M 4.89M 4.89M 4.89M 6.8M 6.8M 6.8M 6.8M 4.42M 4.42M 4.42M 4.42M 3.98M
    Cost & Expenses
    		 515.15M 631.5M 610.43M 588.65M 594.8M 490.84M 516.35M 532.44M 513.24M 487.69M 442.61M 409.44M 384.18M 371.24M 358.01M 351.94M
    Income Tax Expense
    		 21.1M 23.01M 21.42M 18.7M 16.78M 11.45M 9.63M 10.51M 11.06M 8.11M 9.16M 9.24M 8.75M 10.18M 9.12M 8.38M
    Shares Outstanding (Basic)
    		 10.18M 10.18M 10.18M 10.18M 10.14M 10.13M 10.16M 10.15M 10.14M 10.06M 10.14M 10.14M 10.14M 10.2M 10.15M 10.17M
    Shares Outstanding (Diluted)
    		 10.18M 10.18M 10.18M 10.18M 10.14M 10.13M 10.16M 10.15M 10.14M 10.06M 10.14M 10.14M 10.14M 10.2M 10.15M 10.17M
    EPS (Basic)
    		 5.32 5.78 5.41 5.46 5.02 4.33 4.07 3.56 3.56 2.88 2.75 2.70 2.72 2.62 2.53 2.29
    EPS (Diluted)
    		 5.32 5.78 5.41 5.46 5.02 4.33 4.07 3.56 3.56 2.88 2.75 2.70 2.72 2.62 2.53 2.29
    EBITDA
    		 105.73M 101.09M 95.29M 87.04M 80.81M 72.99M 65.6M 68.1M 65.7M 61.15M 62.84M 62.4M 61.79M 62.23M 60.37M 57.44M
    EBIT
    		 81.17M 76.79M 71.48M 61.87M 55.85M 48.09M 42.75M 45.01M 44.31M 39.78M 39.26M 38.7M 38.22M 39.14M 37.8M 35.55M
    Depreciation & Amortization
    		 26.32M 32.64M 32.81M 39.01M 38.79M 38.49M 38.24M 38.19M 38.17M 38.04M 37.92M 36.98M 36.45M 35.42M 34.88M 34.54M

    Add to Watchlist